中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 40 Issue 7
Jul.  2024
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2024  >  40(7): 1450-1458

Role of lipophagy in the prevention and treatment of nonalcoholic fatty liver disease

DOI: 10.12449/JCH240725
  • 1.

    The First Clinical College of Hubei University of Chinese Medicine，Wuhan 430061，China

  • 2.

    Department of Hepatology，The Affiliated Hospital of Hubei University of Chinese Medicine，Wuhan 430061，China

  • 3.

    Department of Hepatology，Hubei Provincial Hospital of Traditional Chinese Medicine，Hubei Key Laboratory of Theoretical and Applied Research of Liver and Kidney in Traditional Chinese Medicine，Wuhan 430061，China

  • 4.

    Hubei Academy of Chinese Medicine，Wuhan 430074，China

Research funding:

General Project of National Natural Science Foundation of China (82274352);

Natural Science Foundation of Hubei Province (2020CFA023);

Natural Science Foundation of Hubei Province (2023AFB426);

Natural Science Foundation of Hubei Province (2023AFD129);

Natural Science Foundation of Hubei Province (2023AFD178)

More Information
  • Corresponding author: XIAO Mingzhong， xmz0001@sohu.com （ORCID： 0000-0002-8432-703X）
  • Received Date: 2023-11-23
  • Accepted Date: 2023-12-22
  • Published Date: 2024-07-25
    Abstract
  • Nowadays， the prevalence of nonalcoholic fatty liver disease （NAFLD） is constantly rising in China and globally， and its incidence rate is increasing year by year， which has seriously affected human life and health. Lipophagy is molecular chaperone-mediated autophagy and has the functions of promoting lipolysis， maintaining the lipid homeostasis of hepatocytes， and alleviating hepatocyte fatty degeneration. Lipophagy has three main processes of lipid droplet catabolism， lipid droplet autophagy， and fatty acid β-oxidation， which are regulated by key genes， receptors， and enzymes. Currently， important advances have been achieved for the intervention methods of traditional Chinese medicine， Western medicine， diet， and exercise in the research on lipophagy， which provides new perspectives for the prevention and treatment strategies for NAFLD.

     

    • FullText(HTML)
  • loading
    • References(61)
  • [1]
    FRIEDMAN SL, NEUSCHWANDER-TETRI BA, RINELLA M, et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med, 2018, 24( 7): 908- 922. DOI: 10.1038/s41591-018-0104-9.
    [2]
    RIAZI K, AZHARI H, CHARETTE JH, et al. The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2022, 7( 9): 851- 861. DOI: 10.1016/S2468-1253(22)00165-0.
    [3]
    ZHOU F, ZHOU JH, WANG WX, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: A systematic review and meta-analysis[J]. Hepatology, 2019, 70( 4): 1119- 1133. DOI: 10.1002/hep.30702.
    [4]
    LAVAL T, OUIMET M. A role for lipophagy in atherosclerosis[J]. Nat Rev Cardiol, 2023, 20( 7): 431- 432. DOI: 10.1038/s41569-023-00885-z.
    [5]
    GLICK D, BARTH S, MACLEOD KF. Autophagy: Cellular and molecular mechanisms[J]. J Pathol, 2010, 221( 1): 3- 12. DOI: 10.1002/path.2697.
    [6]
    ZHOU KB, YAO PB, HE J, et al. Lipophagy in nonliver tissues and some related diseases: Pathogenic and therapeutic implications[J]. J Cell Physiol, 2019, 234( 6): 7938- 7947. DOI: 10.1002/jcp.27988.
    [7]
    SCHOTT MB, WELLER SG, SCHULZE RJ, et al. Lipid droplet size directs lipolysis and lipophagy catabolism in hepatocytes[J]. J Cell Biol, 2019, 218( 10): 3320- 3335. DOI: 10.1083/jcb.201803153.
    [8]
    ZHANG S, PENG XQ, YANG S, et al. The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders[J]. Cell Death Dis, 2022, 13( 2): 132. DOI: 10.1038/s41419-022-04593-3.
    [9]
    KIM J, KUNDU M, VIOLLET B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1[J]. Nat Cell Biol, 2011, 13( 2): 132- 141. DOI: 10.1038/ncb2152.
    [10]
    EGAN DF, SHACKELFORD DB, MIHAYLOVA MM, et al. Phosphorylation of ULK1(hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy[J]. Science, 2011, 331( 6016): 456- 461. DOI: 10.1126/science.1196371.
    [11]
    ZHANG ZL, YAO Z, CHEN YF, et al. Lipophagy and liver disease: New perspectives to better understanding and therapy[J]. Biomed Pharmacother, 2018, 97: 339- 348. DOI: 10.1016/j.biopha.2017.07.168.
    [12]
    SCHULZE RJ, MCNIVEN MA. Lipid droplet formation and lipophagy in fatty liver disease[J]. Semin Liver Dis, 2019, 39( 3): 283- 290. DOI: 10.1055/s-0039-1685524.
    [13]
    JONAS W, SCHWERBEL K, ZELLNER L, et al. Alterations of lipid profile in livers with impaired lipophagy[J]. Int J Mol Sci, 2022, 23( 19): 11863. DOI: 10.3390/ijms231911863.
    [14]
    HAN SL, QIAN YC, LIMBU SM, et al. Lipolysis and lipophagy play individual and interactive roles in regulating triacylglycerol and cholesterol homeostasis and mitochondrial form in zebrafish[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2021, 1866( 9): 158988. DOI: 10.1016/j.bbalip.2021.158988.
    [15]
    ROBICHAUD S, FAIRMAN G, VIJITHAKUMAR V, et al. Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells[J]. Autophagy, 2021, 17( 11): 3671- 3689. DOI: 10.1080/15548627.2021.1886839.
    [16]
    SETTEMBRE C, de CEGLI R, MANSUETO G, et al. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop[J]. Nat Cell Biol, 2013, 15( 6): 647- 658. DOI: 10.1038/ncb2718.
    [17]
    XIONG J, WANG KZ, HE JP, et al. TFE3 alleviates hepatic steatosis through autophagy-induced lipophagy and PGC1α-mediated fatty acid β-oxidation[J]. Int J Mol Sci, 2016, 17( 3): 387. DOI: 10.3390/ijms17030387.
    [18]
    LIN YC, CHANG PF, LIN HF, et al. Variants in the autophagy-related gene IRGM confer susceptibility to non-alcoholic fatty liver disease by modulating lipophagy[J]. J Hepatol, 2016, 65( 6): 1209- 1216. DOI: 10.1016/j.jhep.2016.06.029.
    [19]
    LI Y, WANG T, LIAO QM, et al. Loss of splicing factor SRSF3 impairs lipophagy through ubiquitination and degradation of Syntaxin17 in hepatocytes[J]. J Lipid Res, 2023, 64( 3): 100342. DOI: 10.1016/j.jlr.2023.100342.
    [20]
    KIM YS, NAM HJ, HAN CY, et al. Liver X receptor alpha activation inhibits autophagy and lipophagy in hepatocytes by dysregulating autophagy-related 4B cysteine peptidase and Rab-8B, reducing mitochondrial fuel oxidation[J]. Hepatology, 2021, 73( 4): 1307- 1326. DOI: 10.1002/hep.31423.
    [21]
    CANG XM, WANG Y, ZENG J, et al. C9orf72 knockdown alleviates hepatic insulin resistance by promoting lipophagy[J]. Biochem Biophys Res Commun, 2022, 588: 15- 22. DOI: 10.1016/j.bbrc.2021.12.018.
    [22]
    WANG Z, ZHANG H. Join the club: ORP8 is a lipophagy receptor[J]. Protein Cell, 2023, 14( 9): 632- 634. DOI: 10.1093/procel/pwad005.
    [23]
    SHROFF A, NAZARKO TY. SQSTM1, lipid droplets and current state of their lipophagy affairs[J]. Autophagy, 2023, 19( 2): 720- 723. DOI: 10.1080/15548627.2022.2094606.
    [24]
    LI Y, YANG P, ZHAO L, et al. CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway[J]. J Lipid Res, 2019, 60( 4): 844- 855. DOI: 10.1194/jlr.M090969.
    [25]
    ZHAO L, ZHANG C, LUO XX, et al. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis[J]. J Hepatol, 2018, 69( 3): 705- 717. DOI: 10.1016/j.jhep.2018.04.006.
    [26]
    DONG ZZ, WEI YJ, TAO M, et al. Activation of the purinergic receptor P2X7 improves hepatosteatosis by promoting lipophagy[J]. FEBS Lett, 2021, 595( 22): 2768- 2780. DOI: 10.1002/1873-3468.14207.
    [27]
    GARCIA-MACIA M, SANTOS-LEDO A, LESLIE J, et al. A mammalian target of rapamycin-perilipin 3(mTORC1-Plin3) pathway is essential to activate lipophagy and protects against hepatosteatosis[J]. Hepatology, 2021, 74( 6): 3441- 3459. DOI: 10.1002/hep.32048.
    [28]
    ZHANG GJ, HAN JX, WANG LL, et al. The vesicular transporter STX11 governs ATGL-mediated hepatic lipolysis and lipophagy[J]. iScience, 2022, 25( 4): 104085. DOI: 10.1016/j.isci.2022.104085.
    [29]
    SCHWERBEL K, KAMITZ A, KRAHMER N, et al. Immunity-related GTPase induces lipophagy to prevent excess hepatic lipid accumulation[J]. J Hepatol, 2020, 73( 4): 771- 782. DOI: 10.1016/j.jhep.2020.04.031.
    [30]
    ZHANG T, LIU JX, SHEN SN, et al. SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity[J]. Cell Death Differ, 2020, 27( 1): 329- 344. DOI: 10.1038/s41418-019-0356-z.
    [31]
    ZHOU YP, ZHONG L, YU SJ, et al. Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy[J]. Aging(Albany NY), 2020, 12( 8): 7350- 7362. DOI: 10.18632/aging.103082.
    [32]
    HE AY, DEAN JM, LU DL, et al. Hepatic peroxisomal β-oxidation suppresses lipophagy via RPTOR acetylation and MTOR activation[J]. Autophagy, 2020, 16( 9): 1727- 1728. DOI: 10.1080/15548627.2020.1797288.
    [33]
    MINAMI Y, HOSHINO A, HIGUCHI Y, et al. Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion[J]. Nat Commun, 2023, 14( 1): 4084. DOI: 10.1038/s41467-023-39404-6.
    [34]
    PARK J, RAH SY, AN HS, et al. Metformin-induced TTP mediates communication between Kupffer cells and hepatocytes to alleviate hepatic steatosis by regulating lipophagy and necroptosis[J]. Metabolism, 2023, 141: 155516. DOI: 10.1016/j.metabol.2023.155516.
    [35]
    YOO J, JEONG IK, AHN KJ, et al. Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy[J]. Metabolism, 2021, 120: 154798. DOI: 10.1016/j.metabol.2021.154798.
    [36]
    ZHANG T, YIN XC, REN FF, et al. Mechanism of growth differentiation factor 11 regulating nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2023, 39( 9): 2103- 2109. DOI: 10.3969/j.issn.1001-5256.2023.09.011.

    张涛, 殷雪翠, 任飞飞, 等. 生长分化因子11(GDF11)调节非酒精性脂肪性肝病的机制研究[J]. 临床肝胆病杂志, 2023, 39( 9): 2103- 2109. DOI: 10.3969/j.issn.1001-5256.2023.09.011.
    [37]
    TUCKER B, LI HT, LONG XX, et al. Fibroblast growth factor 21 in non-alcoholic fatty liver disease[J]. Metabolism, 2019, 101: 153994. DOI: 10.1016/j.metabol.2019.153994.
    [38]
    JUNG EJ, SUNG KW, BAE TH, et al. The N-degron pathway mediates lipophagy: The chemical modulation of lipophagy in obesity and NAFLD[J]. Metabolism, 2023, 146: 155644. DOI: 10.1016/j.metabol.2023.155644.
    [39]
    YANG XS, DENG YD, TU YL, et al. Nobiletin mitigates NAFLD via lipophagy and inflammation[J]. Food Funct, 2022, 13( 19): 10186- 10199. DOI: 10.1039/d2fo01682f.
    [40]
    ZHANG H, LU JF, LIU H, et al. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease[J]. Pharmacol Res, 2021, 174: 105964. DOI: 10.1016/j.phrs.2021.105964.
    [41]
    YANG WW, JIANG CH, WANG ZG, et al. Cyclocarya paliurus extract attenuates hepatic lipid deposition in HepG2 cells by the lipophagy pathway[J]. Pharm Biol, 2020, 58( 1): 838- 844. DOI: 10.1080/13880209.2020.1803365.
    [42]
    ZHOU WL, YAN X, ZHAI YY, et al. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy[J]. Phytomedicine, 2022, 103: 154235. DOI: 10.1016/j.phymed.2022.154235.
    [43]
    GUAN LL, GUO L, ZHANG H, et al. Naringin protects against non-alcoholic fatty liver disease by promoting autophagic flux and lipophagy[J]. Mol Nutr Food Res, 2024, 68( 3): e2200812. DOI: 10.1002/mnfr.202200812.
    [44]
    CHEN XT, CHAN H, ZHANG L, et al. The phytochemical polydatin ameliorates non-alcoholic steatohepatitis by restoring lysosomal function and autophagic flux[J]. J Cell Mol Med, 2019, 23( 6): 4290- 4300. DOI: 10.1111/jcmm.14320.
    [45]
    WANG Y, ZHAO HL, LI X, et al. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy[J]. J Nutr Biochem, 2019, 73: 108214. DOI: 10.1016/j.jnutbio.2019.07.005.
    [46]
    LEI P, HU YQ, GAO P, et al. Sulforaphane ameliorates hepatic lipid metabolism via modulating lipophagy in vivo and in vitro[J]. J Agric Food Chem, 2022, 70( 48): 15126- 15133. DOI: 10.1021/acs.jafc.2c06311.
    [47]
    MASUDA M, YOSHIDA-SHIMIZU R, MORI Y, et al. Sulforaphane induces lipophagy through the activation of AMPK-mTOR-ULK1 pathway signaling in adipocytes[J]. J Nutr Biochem, 2022, 106: 109017. DOI: 10.1016/j.jnutbio.2022.109017.
    [48]
    YANG SW, LIU T, HU CX, et al. Ginsenoside compound K protects against obesity through pharmacological targeting of glucocorticoid receptor to activate lipophagy and lipid metabolism[J]. Pharmaceutics, 2022, 14( 6): 1192. DOI: 10.3390/pharmaceutics14061192.
    [49]
    LIU JX, ZHANG T, ZHU JZ, et al. Honokiol attenuates lipotoxicity in hepatocytes via activating SIRT3-AMPK mediated lipophagy[J]. Chin Med, 2021, 16( 1): 115. DOI: 10.1186/s13020-021-00528-w.
    [50]
    FUKAYA M, SATO Y, KONDO S, et al. Quercetin enhances fatty acid β-oxidation by inducing lipophagy in AML12 hepatocytes[J]. Heliyon, 2021, 7( 6): e07324. DOI: 10.1016/j.heliyon.2021.e07324.
    [51]
    ZENG HM, GUO XP, ZHOU F, et al. Quercetin alleviates ethanol-induced liver steatosis associated with improvement of lipophagy[J]. Food Chem Toxicol, 2019, 125: 21- 28. DOI: 10.1016/j.fct.2018.12.028.
    [52]
    PARK M, SHARMA A, BAEK H, et al. Stevia and stevioside attenuate liver steatosis through PPARα-mediated lipophagy in db/db mice hepatocytes[J]. Antioxidants(Basel), 2022, 11( 12): 2496. DOI: 10.3390/antiox11122496.
    [53]
    LEE DH, PARK SH, HUH YH, et al. Iridoids of Valeriana fauriei contribute to alleviating hepatic steatosis in obese mice by lipophagy[J]. Biomed Pharmacother, 2020, 125: 109950. DOI: 10.1016/j.biopha.2020.109950.
    [54]
    GAO Y, ZHANG W, ZENG LQ, et al. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy[J]. Redox Biol, 2020, 36: 101635. DOI: 10.1016/j.redox.2020.101635.
    [55]
    WU LX, XU YC, HOGSTRAND C, et al. Lipophagy mediated glucose-induced changes of lipid deposition and metabolism via ROS dependent AKT-Beclin1 activation[J]. J Nutr Biochem, 2022, 100: 108882. DOI: 10.1016/j.jnutbio.2021.108882.
    [56]
    LIU XY, ZHAO T, WEI XL, et al. Dietary phosphorus reduced hepatic lipid deposition by activating ampk pathway and Beclin1 phosphorylation levels to activate lipophagy in Tilapia Oreochromis niloticus[J]. Front Nutr, 2022, 9: 841187. DOI: 10.3389/fnut.2022.841187.
    [57]
    BYUN S, SEOK S, KIM YC, et al. Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase[J]. Nat Commun, 2020, 11( 1): 807. DOI: 10.1038/s41467-020-14384-z.
    [58]
    RAIMUNDO N. Feeding and lipophagy: It takes guts to deliver[J]. EMBO J, 2022, 41( 17): e112180. DOI: 10.15252/embj.2022112180.
    [59]
    LI RD, LI GK, HAI Y, et al. The effect of aerobic exercise on the lipophagy of adipose tissue in obese male mice[J]. Chem Phys Lipids, 2022, 247: 105225. DOI: 10.1016/j.chemphyslip.2022.105225.
    [60]
    YANG YJ, LI X, LIU ZH, et al. Moderate treadmill exercise alleviates NAFLD by regulating the biogenesis and autophagy of lipid droplet[J]. Nutrients, 2022, 14( 22): 4910. DOI: 10.3390/nu14224910.
    [61]
    LI H, DUN YS, ZHANG WL, et al. Exercise improves lipid droplet metabolism disorder through activation of AMPK-mediated lipophagy in NAFLD[J]. Life Sci, 2021, 273: 119314. DOI: 10.1016/j.lfs.2021.119314.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (505) PDF downloads(64) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return